Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R
Research (Wash D C). 2025; 8:0612.
PMID: 40046513
PMC: 11880593.
DOI: 10.34133/research.0612.
Heo Y, Kim W, Cho Y, Jung J, Kim N, Choi I
Genes Genomics. 2025; .
PMID: 39849190
DOI: 10.1007/s13258-024-01614-7.
Stickler S, Lang C, Rieche M, Eggerstorfer M, Hohenegger M, Hochmair M
Sci Rep. 2025; 15(1):2893.
PMID: 39843506
PMC: 11754616.
DOI: 10.1038/s41598-025-87027-2.
Kerdkumthong K, Roytrakul S, Songsurin K, Pratummanee K, Runsaeng P, Obchoei S
Biomolecules. 2024; 14(8).
PMID: 39199357
PMC: 11352417.
DOI: 10.3390/biom14080969.
Kulkarni A, Mohan V, Tang T, Post L, Chan Y, Manning M
EMBO Rep. 2024; 25(9):3944-3969.
PMID: 39103676
PMC: 11387499.
DOI: 10.1038/s44319-024-00217-3.
Isolated Rectal Neurofibroma: A Case Report and Literature Review.
He Z, Khan S, Slaton A
Cureus. 2024; 16(6):e63323.
PMID: 39070511
PMC: 11283373.
DOI: 10.7759/cureus.63323.
Case report: Treatment response of NF-1-associated bladder ganglioneuroma to trametinib.
Chan M, Fung K, Ng W, Luk H, Ku D, Liu A
Front Oncol. 2024; 14:1433073.
PMID: 39070150
PMC: 11272527.
DOI: 10.3389/fonc.2024.1433073.
Biological characteristics and clinical management of uveal and conjunctival melanoma.
Kastelan S, Didovic Pavicic A, Pasalic D, Nikuseva-Martic T, canovic S, Kovacevic P
Oncol Res. 2024; 32(8):1265-1285.
PMID: 39055896
PMC: 11267116.
DOI: 10.32604/or.2024.048437.
The genetic spectrum of variants in 10 unrelated Chinese families with neurofibromatosis type 1.
Chen S, Cheng H, Zhao G
Neurosciences (Riyadh). 2024; 29(3):177-183.
PMID: 38981629
PMC: 11305348.
DOI: 10.17712/nsj.2024.3.20230003.
Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care.
Miyagishima K, Qiao F, Stasheff S, Nadal-Nicolas F
Vision (Basel). 2024; 8(2).
PMID: 38804352
PMC: 11130890.
DOI: 10.3390/vision8020031.
Contributions towards Understanding Neurofibromatosis 1.
Atsoniou K, Giannopoulou E, Georganta E, Skoulakis E
Cells. 2024; 13(8.
PMID: 38667335
PMC: 11048932.
DOI: 10.3390/cells13080721.
Pediatric low-grade glioma models: advances and ongoing challenges.
Yvone G, Breunig J
Front Oncol. 2024; 13:1346949.
PMID: 38318325
PMC: 10839015.
DOI: 10.3389/fonc.2023.1346949.
Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas.
Hu X, Li W, Zeng K, Xu Z, Li C, Kang Z
BMC Med. 2023; 21(1):230.
PMID: 37400844
PMC: 10318822.
DOI: 10.1186/s12916-023-02927-2.
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer.
Auf der Maur P, Trefny M, Baumann Z, Vulin M, Correia A, Diepenbruck M
Cell Rep Med. 2023; 4(4):101002.
PMID: 37044095
PMC: 10140479.
DOI: 10.1016/j.xcrm.2023.101002.
Clinical characteristics and in silico analysis of congenital pseudarthrosis of the tibia combined with neurofibromatosis type 1 caused by a novel mutation.
Xu J, Zhang Y, Zhu K, Li J, Guan Y, He X
Front Genet. 2022; 13:991314.
PMID: 36246612
PMC: 9553987.
DOI: 10.3389/fgene.2022.991314.
Small round cell sarcomas.
Cidre-Aranaz F, Watson S, Amatruda J, Nakamura T, Delattre O, de Alava E
Nat Rev Dis Primers. 2022; 8(1):66.
PMID: 36202860
DOI: 10.1038/s41572-022-00393-3.
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma.
Rachiglio A, Sacco A, Forgione L, Esposito C, Chicchinelli N, Normanno N
Explor Target Antitumor Ther. 2022; 1(1):53-70.
PMID: 36046264
PMC: 9400741.
DOI: 10.37349/etat.2020.00004.
Current concepts of neurofibromatosis type 1: pathophysiology and treatment.
Choi J, An S, Lim S
Arch Craniofac Surg. 2022; 23(1):6-16.
PMID: 35255591
PMC: 8901593.
DOI: 10.7181/acfs.2022.00633.
zMADM (zebrafish mosaic analysis with double markers) for single-cell gene knockout and dual-lineage tracing.
Xu B, Kucenas S, Zong H
Proc Natl Acad Sci U S A. 2022; 119(9).
PMID: 35197298
PMC: 8892518.
DOI: 10.1073/pnas.2122529119.
The Different Impact of ERK Inhibition on Neuroblastoma, Astrocytoma, and Rhabdomyosarcoma Cell Differentiation.
Lebedev T, Vagapova E, Prassolov V
Acta Naturae. 2022; 13(4):69-77.
PMID: 35127149
PMC: 8807533.
DOI: 10.32607/actanaturae.11461.
